SCHEMBL4664168

SCHEMBL4664168

NC(=O)CCc1cccc(C(F)(F)F)n1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
P2RX7 Q99572 1/20 0.50
MAOB P27338 1/20 0.47
ADORA2A P29274 1/20 0.39
PGK1 P00558 1/20 0.39
PGK2 P07205 1/20 0.39
GPR52 Q9Y2T5 1/20 0.38
TAS2R14 Q9NYV8 1/20 0.38
AURKA O14965 1/20 0.37
MBOAT4 Q96T53 1/20 0.37
GRM2 Q14416 1/20 0.37
SYK P43405 1/20 0.37
GLS O94925 1/20 0.37
JAK2 O60674 1/20 0.36
HCRTR1 O43613 2/20 0.36
HCRTR2 O43614 2/20 0.36
PLA2G10 O15496 1/20 0.36
PLA2G2A P14555 1/20 0.36
PLA2G5 P39877 1/20 0.36
AHR P35869 1/20 0.36
PDE4D Q08499 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19837388 0.85 P2RX7 (0.47) P2RX7MAOBADORA2ATAS2R14MBOAT4
SCHEMBL2312720 0.83 MAOB (0.55) P2RX7MAOBADORA2APGK1PGK2
SCHEMBL31645933 0.83 MAOB (0.55) P2RX7MAOBADORA2APGK1PGK2
SCHEMBL23343864 0.78 P2RX7 (0.45) P2RX7MAOBPGK1PGK2TAS2R14
SCHEMBL25402832 0.78 P2RX7 (0.45) P2RX7MAOBADORA2AMBOAT4SYK
SCHEMBL26046016 0.77 P2RX7 (0.49) P2RX7MAOBADORA2APGK1PGK2
SCHEMBL27825129 0.75 P2RX7 (0.44) P2RX7MAOBADORA2ATAS2R14MBOAT4
SCHEMBL4664166 0.75 P2RX7 (0.46) P2RX7
SCHEMBL23015742 0.75 PARP1 (0.47) PGK1PGK2
SCHEMBL868879 0.75 P2RX7 (0.50) P2RX7MAOBADORA2APGK1PGK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3328853-B1 SUBSTITUTED AMIDE DERIVATIVES HAVING MULTIMODAL ACTIVITY AGAINST PAIN ESTEVE PHARMACEUTICALS SA (ES) 2019-09-11 EP claimed
EP-3328853-A1 SUBSTITUTED AMIDE DERIVATIVES HAVING MULTIMODAL ACTIVITY AGAINST PAIN Laboratorios Del. Dr. Esteve, S.A. (ES) 2018-06-06 EP claimed
WO-2017016669-A1 SUBSTITUTED AMIDE DERIVATIVES HAVING MULTIMODAL ACTIVITY AGAINST PAIN LABORATORIOS DEL DR. ESTEVE, S.A. (ES) 2017-02-02 WO claimed
EP-2007717-A1 NOVEL SULFONAMIDE COMPOUNDS Actelion Pharmaceuticals Ltd. (CH) 2008-12-31 EP claimed
WO-2007116374-A1 NOVEL SULFONAMIDE COMPOUNDS ACTELION PHARMACEUTICALS LTD (CH) 2007-10-18 WO claimed
EP-3328853-A1 SUBSTITUTED AMIDE DERIVATIVES HAVING MULTIMODAL ACTIVITY AGAINST PAIN Laboratorios Del. Dr. Esteve, S.A. (ES) 2018-06-06 EP disclosed
WO-2017016669-A1 SUBSTITUTED AMIDE DERIVATIVES HAVING MULTIMODAL ACTIVITY AGAINST PAIN LABORATORIOS DEL DR. ESTEVE, S.A. (ES) 2017-02-02 WO disclosed
EP-2007717-A1 NOVEL SULFONAMIDE COMPOUNDS Actelion Pharmaceuticals Ltd. (CH) 2008-12-31 EP disclosed
WO-2007116374-A1 NOVEL SULFONAMIDE COMPOUNDS ACTELION PHARMACEUTICALS LTD (CH) 2007-10-18 WO disclosed